1 Result: PepGen
FDA Notifies PepGen, LL Flooring Becomes Takeover Target, JOYY Beats Estimates: Key Updates and Market Movements
May 31st, 2023
PepGen Inc. (Nasdaq: PEPG), a biotechnology company specializing in genetic therapies, received a clinical hold notice from the U.S. Food and Drug Administration (FDA) for their Investigational New Drug Application (IND) related to a Phase 1 study of. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Wall Street Eyes Ciena, lululemon, and Broadcom Ahead of Earnings
December 07th, 2025Earnings Watch: What to Expect from Electrovaya, Nordson, and Synopsys
December 07th, 2025Earnings on Deck: AeroVironment, AutoZone, and Core & Main Set to Report
December 07th, 2025December 05th, 2025FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025
Member Login